Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024
SHANGHAI, March 5, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will report financial results for the full year of 2023 ended December 31, 2023 and provide a business update on March 28, 2024.
- SHANGHAI, March 5, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will report financial results for the full year of 2023 ended December 31, 2023 and provide a business update on March 28, 2024.
- The Company will hold live conference calls in English and Mandarin on March 28, 2024 Beijing Time.
- The English session of the conference call will be held at 9:00 AM on March 28, 2024 Beijing Time (9:00 PM U.S. Eastern Time on March 27, 2024) and the Mandarin session of the conference call will be held at 11:00 AM Beijing Time on the same day (11:00 PM U.S. Eastern Time on March 27, 2024).
- The conference calls can be accessed by the following links:
Time: 9:00 AM Beijing Time, Thursday, March 28, 2024 (9:00 PM U.S. Eastern Time on March 27, 2024)